CMR Short Reviews
- The Concept of CMR
  Historical background on global cardiometabolic risk, epidemiological aspects of obesity and type 2 diabetes, ABCs of cardiovascular disease risk factors, intra-abdominal adiposity, metabolic syndrome and contribution to cardiometabolic risk.
- Evaluating CMR
  Research and clinical tools to identify individuals with excess intra-abdominal adiposity and quantify their risk of diabetes and cardiovascular disease (global cardiometabolic risk).
- Managing CMR
  Notions and practical tools to better manage the abdominally obese patient with excess intra-abdominal adiposity and related clustering abnormalities.
Documentation Centre
- Slides, videos and more

Documentation Centre

September 25, 2015: A randomized, controlled trial of 3.0 mg of liraglutide in weight management. N Engl J Med. 2015;373:11-22; Pi-Sunyer X, Astrup A, Fujioka K, Greenway F, Halpern A, Krempf M, Lau DC, le Roux CW, Violante Ortiz R, Jensen CB, Wilding JP; SCALE Obesity and Prediabetes NN8022-1839 Study Group

Description of this Publication

By clicking on this link, you will leave the INTERNATIONAL CHAIR ON CARDIOMETABOLIC RISK website

Key Words
Documentation Centre, Documentation Centre, Weight Loss

The content of this website is provided for educational and informational purposes only and is not to be used for medical advice, diagnosis or treatment. Use of this site is subject to the terms and conditions contained in our Legal Notices.